Fundraising FoxNovartis Venture Fund — 2020 Investments
7 investments dated 2020 · listed companies and verified rows first · show all
GentiBio develops engineered regulatory T-cell (EngTreg) therapies designed to reset the immune system and treat autoimmune and acute inflammatory diseases.
BiotechHealthtechMedical Devices
Jane Buckner(Scientific Co-founder (President, Benaroya Research Institute))Chandra Patel(Co-founder & SVP, Research and Development Operations)inDavid Rawlings(Scientific Co-founder and Senior Scientific Advisor)Andy Scharenberg(Scientific Co-founder, SAB Chair)Andy Walker(President and CEO)inTom Wickham(Chief Scientific Officer)
Co-investorsOrbiMedJDRF T1D FundRA Capital
CatalYm develops immunotherapies for solid tumors by neutralizing GDF-15, a factor cancer cells use to suppress immune responses and resist treatment.
BiotechDeep TechHealthtechMunich, DE
Jörg Wischhusen(Scientific Co-founder)Scott Clarke(Chief Executive Officer)inPeter Garcia(Chief Financial Officer)Sujata Rao(Chief Medical Officer)inStefan Ries(Chief Scientific Officer and Head of Munich Site)inAndrea Goddard(Chief Technical Officer)in
Co-investorsBioqube VenturesBrandon CapitalJeito CapitalForbionBayern KapitalBioGeneration Ventures+2 more
BiotechCambridge, US
Ed Freedman(Executive Officer, Director)
BoardCary Pfeffer(Executive Officer, Director)inRobert Tepper(Director)inCharles Homcy(Director)
Co-investorsThird Rock Ventures
FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors.
BiotechDeep TechHealthtechBasel, CH
Tarig Bashir(Chief Executive Officer (CEO))inJens Würthner(Chief Medical Officer (CMO))Frank Zenke(Chief Scientific Officer (CSO))in
Co-investorsM VenturesPfizer Venture InvestmentsOmega Funds
Rappta Therapeutics develops small molecule compounds that reactivate protein phosphatase 2A (PP2A) to treat cancer by restoring the enzyme's tumor suppressor function.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsAdvent Life SciencesNovo Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ImmPACT Bio USA Inc.Rappta Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.